Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner

Wei Hua Pan, Ping Xin, Vuong Bui, Gary Clawson

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A major limitation to the effectiveness of ribozymes is definition of accessible sites in targeted RNAs. Although library selection procedures have been developed, they are generally difficult to perform and have not been widely employed. Here we describe a selection technology that utilizes a randomized, active hammerhead ribozyme (Rz) library in an iterative manner. After two rounds of binding under inactive conditions, the selected, active Rz library is incubated with target RNA, and the sites of cleavage are identified on sequencing gels. We performed this library-selection protocol using human papillomavirus type 16 E6/E7 mRNA as target and constructed Rz targeted to the identified sites. Rz targeted to sites identified with this procedure were generally highly active in vitro and, more importantly, they were highly active in cell culture, whereas their catalytically inactive counterparts were not. This protocol can be used to identify a set of potential target sites within a relatively short time.

Original languageEnglish (US)
Pages (from-to)129-139
Number of pages11
JournalMolecular Therapy
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Catalytic RNA
Libraries
RNA Cleavage
Human papillomavirus 16
Cell Culture Techniques
Gels
RNA
Technology
Messenger RNA
hammerhead ribozyme

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

@article{6ebfda3db96c4e25aadd8b6dfce91f88,
title = "Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner",
abstract = "A major limitation to the effectiveness of ribozymes is definition of accessible sites in targeted RNAs. Although library selection procedures have been developed, they are generally difficult to perform and have not been widely employed. Here we describe a selection technology that utilizes a randomized, active hammerhead ribozyme (Rz) library in an iterative manner. After two rounds of binding under inactive conditions, the selected, active Rz library is incubated with target RNA, and the sites of cleavage are identified on sequencing gels. We performed this library-selection protocol using human papillomavirus type 16 E6/E7 mRNA as target and constructed Rz targeted to the identified sites. Rz targeted to sites identified with this procedure were generally highly active in vitro and, more importantly, they were highly active in cell culture, whereas their catalytically inactive counterparts were not. This protocol can be used to identify a set of potential target sites within a relatively short time.",
author = "Pan, {Wei Hua} and Ping Xin and Vuong Bui and Gary Clawson",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0000-000X(00)00000-0",
language = "English (US)",
volume = "7",
pages = "129--139",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "1",

}

Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner. / Pan, Wei Hua; Xin, Ping; Bui, Vuong; Clawson, Gary.

In: Molecular Therapy, Vol. 7, No. 1, 01.01.2003, p. 129-139.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner

AU - Pan, Wei Hua

AU - Xin, Ping

AU - Bui, Vuong

AU - Clawson, Gary

PY - 2003/1/1

Y1 - 2003/1/1

N2 - A major limitation to the effectiveness of ribozymes is definition of accessible sites in targeted RNAs. Although library selection procedures have been developed, they are generally difficult to perform and have not been widely employed. Here we describe a selection technology that utilizes a randomized, active hammerhead ribozyme (Rz) library in an iterative manner. After two rounds of binding under inactive conditions, the selected, active Rz library is incubated with target RNA, and the sites of cleavage are identified on sequencing gels. We performed this library-selection protocol using human papillomavirus type 16 E6/E7 mRNA as target and constructed Rz targeted to the identified sites. Rz targeted to sites identified with this procedure were generally highly active in vitro and, more importantly, they were highly active in cell culture, whereas their catalytically inactive counterparts were not. This protocol can be used to identify a set of potential target sites within a relatively short time.

AB - A major limitation to the effectiveness of ribozymes is definition of accessible sites in targeted RNAs. Although library selection procedures have been developed, they are generally difficult to perform and have not been widely employed. Here we describe a selection technology that utilizes a randomized, active hammerhead ribozyme (Rz) library in an iterative manner. After two rounds of binding under inactive conditions, the selected, active Rz library is incubated with target RNA, and the sites of cleavage are identified on sequencing gels. We performed this library-selection protocol using human papillomavirus type 16 E6/E7 mRNA as target and constructed Rz targeted to the identified sites. Rz targeted to sites identified with this procedure were generally highly active in vitro and, more importantly, they were highly active in cell culture, whereas their catalytically inactive counterparts were not. This protocol can be used to identify a set of potential target sites within a relatively short time.

UR - http://www.scopus.com/inward/record.url?scp=0037219310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037219310&partnerID=8YFLogxK

U2 - 10.1016/S0000-000X(00)00000-0

DO - 10.1016/S0000-000X(00)00000-0

M3 - Article

C2 - 12573626

AN - SCOPUS:0037219310

VL - 7

SP - 129

EP - 139

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 1

ER -